Literature DB >> 17006715

Acute and chronic effects of ketamine upon human memory: a review.

Celia J A Morgan1, H Valerie Curran.   

Abstract

INTRODUCTION: Ketamine is attracting increasing research interest not only because of its powerful amnestic effects but also as a putative model of schizophrenia and as a substance with an expanding following of recreational users.
OBJECTIVE: This article reviews the existing literature on the effects of acute ketamine on the memory of healthy volunteers and of repeated doses of ketamine in recreational users. CURRENT TRENDS: Although there have been relatively few, often methodologically diverse, studies to date of the mnemonic effects of ketamine, there is an emerging consensus that an acute dose of the drug impairs the manipulation of information in working memory and produces decrements in the encoding of information into episodic memory. Preliminary evidence suggests that ketamine may differ from other classic amnestic drugs in impairing aspects of semantic memory. Acute-on-chronic effects in ketamine users generally mimic the pattern seen in controlled studies with healthy volunteers. However, chronic ketamine use may be associated with a more specific pattern of memory decrements and with episodic memory impairment, which might not abate following cessation of use. FUTURE TRENDS: An important aim of future research should be to detail the specificity of ketamine's amnestic effects on both a neuropharmacological and a cognitive level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006715     DOI: 10.1007/s00213-006-0572-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  104 in total

1.  A role for NMDA-receptor channels in working memory.

Authors:  J E Lisman; J M Fellous; X J Wang
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

2.  Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.

Authors:  L A Hetem; J M Danion; P Diemunsch; C Brandt
Journal:  Psychopharmacology (Berl)       Date:  2000-10       Impact factor: 4.530

3.  Reduction of psychotomimetic side effects of Ketalar (ketamine) by Rohypnol (flunitrazepam). A randomized, double-blind trial.

Authors:  I Freuchen; J Ostergaard; J B Kühl; B O Mikkelsen
Journal:  Acta Anaesthesiol Scand       Date:  1976       Impact factor: 2.105

4.  Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment.

Authors:  F Sams-Dodd
Journal:  J Neurosci Methods       Date:  1995-07       Impact factor: 2.390

Review 5.  Neural bases of learning and memory: functional neuroimaging evidence.

Authors:  R Cabeza; L Nyberg
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

6.  Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.

Authors:  Deepak Cyril D'Souza; Walid Michel Abi-Saab; Steven Madonick; Kimberlee Forselius-Bielen; Anne Doersch; Gabriel Braley; Ralitza Gueorguieva; Thomas B Cooper; John Harrison Krystal
Journal:  Biol Psychiatry       Date:  2005-03-15       Impact factor: 13.382

7.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study.

Authors:  Celia J A Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

8.  Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users.

Authors:  Celia J A Morgan; Marcio Riccelli; Charles H Maitland; H Valerie Curran
Journal:  Drug Alcohol Depend       Date:  2004-09-06       Impact factor: 4.492

9.  Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

Authors:  B Adams; B Moghaddam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 10.  Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits.

Authors:  Paul C Fletcher; Garry D Honey
Journal:  Trends Cogn Sci       Date:  2006-03-10       Impact factor: 20.229

View more
  64 in total

Review 1.  Neuroanatomical and neurochemical substrates of timing.

Authors:  Jennifer T Coull; Ruey-Kuang Cheng; Warren H Meck
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

Review 2.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 3.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 4.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 5.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

6.  A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists.

Authors:  Sophie Dix; Gary Gilmour; Slavinka Potts; Janice W Smith; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

Review 7.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

8.  A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.

Authors:  Janice W Smith; Francois Gastambide; Gary Gilmour; Sophie Dix; Julie Foss; Kirstie Lloyd; Nadia Malik; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

Review 9.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

10.  Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Authors:  Garry D Honey; Philip R Corlett; Anthony R Absalom; Michael Lee; Edith Pomarol-Clotet; Graham K Murray; Peter J McKenna; Edward T Bullmore; David K Menon; Paul C Fletcher
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.